Name change to Kyntra Bio reflects the newly sharpened focus of the Company on novel therapies with potential for outsized impact in oncology and ...

Name change to Kyntra Bio reflects the newly sharpened focus of the Company on novel therapies with potential for outsized impact in oncology and rare diseaseKyntra Bio will begin trading on Nasdaq un ...

M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.

The space features private infusion chairs and one-on-one care. Hospital officials said the center allows treatment for ...

Medscape Medical News talked with researcher Stacie Dusetzina about the prospects for a single-payer program to help with the ...

Backed by more than a dozen prominent investors, the startup is advancing into human testing a drug it believes capable of ...

Detailed price information for Fibrogen Inc CS (FGEN-Q) from The Globe and Mail including charting and trades.

Because the risk of many conditions increases with age, doctors generally recommend more frequent lab testing as you get ...

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

More families are choosing plant-based diets for their children, but are children’s nutritional needs being adequately met?

FDA approves new denosumab biosimilars, enhancing treatment options for osteoporosis and bone metastases while driving ...

Having an episiotomy, a surgical cut to the vagina during childbirth, doubles the risk of postpartum hemorrhage (PPH) in ...